CD4 and coinfection: Additionally, assessment of the accuracy of symptoms, signs, or laboratory tests in LMIC for diagnosis of PCP, rates of co-infection that may confound diagnosis [14], PCP case fatality, CD4 count at presentation, treatment strategies, and efficacy of prophylaxis or antiretroviral therapy (ART) in reducing risk of PCP was undertaken.